ASCO-SITC Clinical Immuno-Oncology Symposium
Thu, 02/23/2017 to Sat, 02/25/2017
Orlando, FL

Join HTG at the ASCO-SITC meeting to learn how we are enabling drug development from discovery to clinic with our universal CDx NGS-based multiplexed profiling panels, extraction-free NGS-based chemistry and our NGS-based automation, the HTG EdgeSeq system.

Thursday, February 23 - Saturday, February 25, 2017
Booth #3
Hyatt Regency Orlando
Orlando, FL

HTG Molecular Diagnostics' & QIAGEN Scientific Symposium
Mon, 03/20/2017 to Tue, 03/21/2017
Paris, France

This no-fee Symposium brings together key molecular and pharma professionals for the opportunity to network, discuss noteworthy and trending topics and exchange information in the fields of immuno-oncology and companion diagnostics.  

Who should attend?

  • Thought leaders who look forward to sharing new ideas and solid science that will move pathology and oncology forward.
  • Pathologists who strive to keep their practice on the leading edge with the newest knowledge and technologies.
  • Translational or clinical development within pharma.

Hot Topics

  • Next-Generation Immuno-Oncology Therapeutics
  • Emerging Biomarkers
  • New Applications of Gene Expression Profiling for Clinical Testing
  • New Treatment Strategies

Monday, March 20, 2017 - Dinner
Tuesday, March 21, 2017 - Symposium
Hotel Marriott Rive Gauche
Paris, France

Confirmed Speakers:

Tuesday, March 21, 2017

Dr. Pierre Saintignym, Center Léon Bérard, France

Integrating The Immune Microenvironment And Cancer Cell Plasticity In The Era Of Precision Medicine In Oncology

Dr. Peter Wild, Institute of Pathology and Molecular Pathology, University of Zürich, Switzerland

MicroRNAs In Serum Of Patients With Testicular Germ Cell Tumors Using A Novel Targeted Multiplex Sequencing Assay

Dr. Patrick Micke, Department of Pathology, Uppsala University Hospital, Sweden

Beyond Targeted Therapy: The Immune Landscape Of Human Lung Cancer

Dr. Jose Antonio Lopez, Instituto Valenciano de Oncología, Spain

The Role Of The HTG Edgeseq System In mRNA Pro ling For Therapeutic Decision Making: The Soft Tissue Sarcoma And Breast Cancer Scenarios


Sample To Insight: The Complete Clinical NGS Work ow

Dr. Carsten Denkert, Institut für Pathologie, Charite Hospital, Germany

mRNA Biomarker In FFPE Tissue – New Approaches To Immuno Oncology In Breast Cancer

Dr. Lakis Liloglou, University of Liverpook, UK

Epigenetic Pro ling Of Extracellular Vesicles (EVS) In Early Diagnosis Of Lung Cancer

Dr. Sharon Barrans, The Leeds Teaching Hospital, UK

Molecular Classi cation Of Aggressive Lymphomas

American Association for Cancer Research (AACR)
Sat, 04/01/2017 to Wed, 04/05/2017
Washington, DC

Join HTG at the 2017 AACR Annual Meeting and learn more about our NGS-based sequencing assays that are automated on the HTG EdgeSeq system.

Daily In-Suite Demos
Schedule a 15-min demo at
Booth: 3215

April 1 - April 5, 2017
Walter E. Washington Convention Center
Washington, DC

Global Congress on Molecular Pathology (AMP Global)
Mon, 04/03/2017 to Wed, 04/05/2017
Berlin, Germany

Join HTG at the Global Congress on Molecular Pathology (AMP Global) 2017 meeting to learn how our collaborators are innovating next-generation pathology with the NGS-based HTG EdgeSeq system and assays. 

Monday, April 3 - Wednesday, April 5, 2017
Stand #22
Congress & Exhibition Center
Berlin, Germany

The European Society of Human Genetics
Sat, 05/27/2017 to Tue, 05/30/2017
Copenhagen, Denmark

Join HTG at the 2017 AACR Annual Meeting and learn more about our NGS-based sequencing assays that are automated on the HTG EdgeSeq system.

Saturday, May 27 - Tuesday, May 30, 2017
Stand #178
Copenhagen, Denmark